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INTRODUCTION
The majority of anaerobic isolates from clinical
specimens belong to the genus Bacteroides (1).
The species included in the ”B. fragilis group” are
considered to be clinically important pathogens as-
sociated with intra-abdominal infections and ab-
scess formation in soft tissues (2). Among these
species, B. fragilis is the most virulent because this
species accounts for over half of the anaerobes iso-
lated from human infections and often causes se-
vere septicemia with a high mortality rate in com-
promised hosts (2, 3). Early diagnosis and treat-
ment with appropriate antibiotics are needed for
patients infected with B. fragilis , but the traditional
culture methods for anaerobes are labor-intensive
and time-comsuming. In addition, if the clinical
samples are not immediately cultured or kept un-
der anaerobic conditions, obligate anaerobes are
often not detected in blood cultures. Various tech-
niques, including analysis of electrophoretic pat-
terns of dehydrogenase (4), bacteriophage typing
(5), analysis of cellular sugar and lipid composi-
tions (6-8) and serology (9-11), have been used for
rapid detection and discrimination of this anaerobe.
However, all of these techniques require viable
cells and many troublesome steps, and none of
them have sufficient specificity and sensitivity to
be used for clinical specimens.
Recently, molecular biology-based techniques
have been shown to be useful for the rapid identifi-
cation of many pathogenic microoganisms (12, 13).
The polymerase chain reaction (PCR) targeting a
specific gene is the most widely used technique in
PCR-dot blot hybridization based on the neuraminidase-encoding
gene is useful for detection of Bacteroides fragilis
Tomomi Kuwahara, Haruyuki Nakayama, Tsuyosi Miki, Keiko Kataoka,
Hideki Arimochi, and Yoshinari Ohnishi
Department of Bacteriology, The University of Tokushima School of Medicine, Tokushima, Japan
Abstract : Bacteroides fragilis is a Gram-negative obligate anaerobe frequently isolated
from clinical specimens and sometimes causes severe septicemia in compromised hosts.
Increasing interest has been shown in the enterotoxigenicity and drug resistance of B .
fragilis in the field of medical microbiology. We previously reported rapid detection of
this anaerobe by nested PCR targeting a neuraminidase-encoding gene nanH. In the
present study, we synthesized a digoxigenin-labeled oligonucleotide probe, NH1,which
is specific for nanH of B . fragilis, and we combined the hybridization assay using NH1
with the nanH -PCR to detect this anaerobe in a bacteremia model mice. In the specific-
ity test, the oligonucleotide probe, NH1, hybridized only to amplification products from
B . fragilis. PCR-dot blot hybridization based on nanH enabled detection of cells of B .
fragilis in blood samples even when the number was as low as 2×103colony-forming
units/ml. These findings suggest that PCR-dot blot hybridization targeting nanH is a
useful procedure for diagnosis of septicemia caused by B . fragilis when viable cells in
blood cannot be detected by the traditional culture techniques. J. Med. Invest. 48 : 60-
65, 2001
Keywords : Bacteroides fragilis, neuraminidase, oligonucleotide probe, septicemia, PCR
Received for publication August 1, 2000 ; accepted September
２６, 2000.
Address correspondence and reprint requests to Yoshinari
Ohnishi, M.D., PhD., Department of Bacteriology, The Univer-
sity of Tokushima School of Medicine, Kuramoto-cho, Tokushima
770-8503,Japan and Fax : +81-886-33-7069.
The Journal of Medical Investigation Vol. 48 2001
６０
diagnostic laboratories because it is quick and it is
suitable for the handling of a large number of spec-
imens (14). Furthermore, PCR amplification ena-
bles the detection of pathogens even in culture-
negative clinical specimens, since this procedure
does not necessarily require viable cells (15). How-
ever, PCR amplification sometimes produces false-
positive results if other bacteria have sequences
similar to those of the designed PCR-primers. In a
previous study, we synthesized two primer sets, F
1-R1 (outer primer set) and F2-R2 (inner primer
set), and used them in nested PCR to amplify the
neuraminidase-encoding gene nanH of B. fragilis
(16). Although these primer sets specifically am-
plified a part of the nanH gene of B. fragilis , one of
the Bacteroides species, B. vulgatus , which possesses
high neuraminidase activity, also produced a sin-
gle band identical to that of B. fragilis in size when
the primer set F1-R1 was used, and this false-pos-
itive band could not be excluded by electrophoresis
alone. In such a case, hybridization tests with
probes specific for the target are usually required
to confirm the specificity of the PCR amplifica-
tions.
In the present study, we developed a digoxigenin-
labeled oligonucleotide probe (named NH1), which
was specific for nanH of B. fragilis , and we used it
in combination with nanH -PCR for a hybridization
assay. We could specifically detect B. fragilis in
blood samples when PCR of a part of the gene
nanH and dot-blot hybridization using NH1 were
applied to model mice with bacteremia induced by
challenge of this anaerobe.
MATERIALS AND METHODS
Bacterial Strains
Sixty strains of B. fragilis, including two refer-
ence strains (ATCC25285 and NCTC9343), were
used in this study. The strains of other species
used were B. distasonis ATCC8503, B. eggerthii
ATCC27754, B. ovatus ATCC8483, B. thetaiotaomicron
ATCC29148, B. uniformis ATCC8492, B. vulgatus
ATCC8482, Porphyromonas asaccharolytica ATCC
25260, P. endodontalis ATCC35406, P. gingivalis
381 and Prevotella corporis JCM8529. All strains
were cultured in GAM broth (Nissui Pharmaceutical
Co., Tokyo, Japan) at 37℃ under anaerobic condi-
tions.
Preparation of Bacterial Cells for PCR
A late log-phase culture (1 ml) of each strain
was centrifuged, washed with 1 ml of phosphate-
buffered saline, and resuspended in 0.1 ml of dis-
tilled water. Each suspension was lysed by heating
at 100℃ for 10 min, and 10 µl of the lysed prepara-
tion was used for PCR amplification of the nanH
gene. PCR amplification of the nanH gene was
performed as described previously (16).
Design of an Oligonucleotide Probe
We compared the nucleotide sequences of the
nanH structural gene of B. fragilis strains YCH46
and TAL2480. The oligonucleotide probe NH1 was
synthesized on the basis of the common sequence
found within F2-and R2-primer annealing sites.
NH1 was labeled with digoxigenin using a DIG-
labeling Kit (Boehringer GmbH, Mannheim, Ger-
many) according to the manufacturer’s instruc-
tions. The nucleotide sequence of NH1 was 5’-
ATCACTATGAGTGACGGTACTTTGGTATTCCC-
3’.
Dot Blot Hybridization
After PCR amplification of the nanH gene, each
reaction mixture was heated at 95℃ for 5 min and
chilled on an ice bath. Then, 5 µl of each amplifica-
tion mixture was spotted on a nylon membrane
and UV-fixed. Southern hybridization was performed
as described by Sambrook et al . (17). The hybridi-
zation with digoxigenin-labeled NH1 was perfomed
in 10 ml of rapid hybridization buffer (Amersham
Co., Ltd.) at 54℃ for 1 hour. Post-hybridization
washes were performed twice at 54℃ with each
washing buffer, 2×SSC (1×SSC being 0.15 mM NaCl
plus 15 mM sodium citrate)-0.1% SDS and 0.1×SSC-
0.1% SDS, respectively. The hybridization signals
were detected according to the manufacturer’s in-
structions using an alkaline phosphatase-labeled
anti-digoxigenin antibody.
Preparation of Blood Samples
Three C57BL/6J mice were intraperitoneally
injected with viable cells of B. fragilis . Blood sam-
ples (0.2 ml) were collected by cardiac puncture at
1, 3 and 6 hours after injection, and 0.1 ml of each
sample was incubated anaerobically on GAM agar
plates. The remainder of the samples were centri-
fuged, washed with 1 ml of 10 mM Tris-HCl and 1
mM EDTA (pH 8.0), and resuspended in 0.1 ml of
lysis buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl,
1.5 mMMgCl2 and 0.1 mg of proteinase K per ml).
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Each suspension was incubated at 65℃ for 1 hour,
boiled in water for 10 min, and chilled on an ice
bath. Ten microliters of each solution was used as
a template for PCR amplification of the nanH gene.
RESULTS AND DISCUSSION
First, we compared the nucleotide sequences of
the nanH gene of B. fragilis strain YCH46 (18) with
strain TAL2480 (19) to design an oligonucleotide
probe that was specific for the nanH gene of B.
fragilis. The nucleotide sequences of nanH from
both strains were highly conserved and showed
91.1% identity (Fig.1). In the present study, we
chose the region at 1057-1088 (numbering in the
YCH46 nanH gene) for a B. fragilis -specific probe
because (i) this region of more than 30 nucleotides
in length is common to both strains, (ii) the guanine
plus cytosine content was relatively high (43.8%),
and (iii) this region corresponded to the middle of
the F2-R2 annealing sites. Since a sufficient amount
of the oligonucleotide probe was easily synthe-
sized using a DNA synthesizer and non-radioisotopic
labeling is required for use in diagnostic laboratories,
we synthesized a digoxigenin-labeled oligonucleotide
probe, NH1, based on this region. The nucleotide
sequence of NH1 is described in Materials and
Methods.
Dot blot hybridization using NH1 was performed
against nanH PCR products from sixty strains of
B. fragilis and ten other strains of related species.
As shown in Fig. 2, positive spots were obtained
from all strains of B. fragilis tested except for strain
KMS2 (spotted at f-4.). However, strain KMS2,
which had initially been identified as B. fragilis,
was reidentified as B. vulgatus when we tested this
strain using an API20A system (bioMerieux). In
addition, none of the products from other species
gave positive spots. Based on these findings, it
Fig. 1. Comparison of the nucleotide se-
quences of nanH from B. fragilis YCH
46 and TAL2480 using Genetyx-Mac soft-
ware Ver8.0.5 (Software Development
Co., Ltd., Tokyo, Japan). In the case of
strain TAL2480, only a partial nucleotide
sequence was available in the DDBJ/
EMBL/Genbank database. The common
residues are indicated by asterisks a-
bove the nucleotide sequences. The po-
sitions of the PCR-primers (underlined)
and oligonucleotide probe, NH1 (double
underlined), are shown below the se-
quence.
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was suggested that (i) the digoxigenin-labeled
oligonucleotide probe, NH1, was specific for nanH
of B. fragilis and (ii) PCR-dot blot hybridization
targeting nanH was useful not only for the identifi-
cation of B. fragilis but also for that of B. vulgatus
(PCR with F1-R1 was positive, but dot blot hybridi-
zation with NH1 was negative.).
To assess the usefulness of nanH-PCR and the
dot blot hybridization assay in clinical specimens,
B. fragilis bacteremia model mice were constructed.
Three 8-week-old male C57BL/6J mice were in-
traperitoneally injected with B. fragilis strain YCH
46, and 0.2 ml blood samples were collected by car-
diac puncture at 1, 3 and 6 hours after injection. Ta-
ble 1 shows the results of the blood culture. Rapid
translocation of B. fragilis cells from the peritoneal
cavity to the blood stream was observed. This find-
ing might represent the pathogenic potential of
this species, but almost all B. fragilis cells appeared
to be cleared from the blood stream within 24
hours in healthy mice.
Nested PCR of the nanH gene was performed
using each blood sample. Fig. 3 shows the findings
of the PCR-dot blot hybridization assay using blood
samples from mouse A in Table 1. The 518 bp bands
of expected size were detected in the samples at
1, 3 and 6 hours (Fig. 3A), while no band was found
in the 0 time control. We confirmed that these were
B. fragilis-specific amplification products by dot
blot hybridization with digoxigenin-labeled NH1
(Fig. 3B). These findings suggested that PCR-dot
blot hybridization based on nanH enables detec-
tion of B. fragilis cells in clinical specimens with a
cell number as low as 2×103cfu/ml, even if the
sample tested contains non-viable cells. As shown
in Fig. 3, the intensity of the PCR bands was not in
proportion to the strength of the hybridization sig-
nals. The reason for this might be that the excess
amount of template produced a large amount of in-
termediate amplification products in the early cy-
cles of amplification and reduced the amount of
specific bands, or that NH1 directly reacted with
genomic DNA contained in blood samples. The
latter case would mean that NH1 would enable di-
rect detection of B. fragilis cells in blood samples
Fig. 2. Dot blot hybridization using digoxigenin-labeled
oligonucleotide probe NH1 against the nanH amplification
products generated by primer F1-R1(A) and F2-R2(B). The
spots from a-1 to e-10 correspond to B. fragilis strains YCH1
to YCH50. The other spots are as follows : f-1, B. fragilis B1 ; f-
2, B. fragilis B2 ; f-3, B. fragilis KMS1 ; f-4, B. fragilis KMS2 ; f-
5, B. fragilis KMS3 ; f-6, B. fragilis KMS4 ; f-7, B. fragilis KMS
5 ; f-8, B. fragilis TDP-101 ; f-9, B. fragilis ATCC25285 ; f-10, B.
fragilis NCTC9343 ; g-1, B. distasonis ATCC8503 ; g-2, B. eggerthii
ATCC27754 ; g-3, B. ovatus ATCC8483 ; g-4, B. thetaiotaomicron
ATCC29148 ; g-5, B. uniformis ATCC8492 ; g-6, B. vulgatus ATCC
8482 ; g-7, Porphyromonas asaccharolytica ATCC25260 ; g-8, Por-
phyromonas endodontalis ATCC35406 ; g-9, Porphyromonas gin-
givalis 381 ; g-10, Prevotella corporis JCM8529.
Table 1. Results of blood cultures from a bacteremia model mice with B. fragilis.
Experimental mouse
Number of B. fragilis
cells used in i. p. injec-
tion (cfu)
Number of B. fragilis cells detected by blood culture (cfu/ml of blood)
0 ha 1 ha 3 ha 6 ha
A
Bb
Cb
8.0×106
5.3×106
5.3×106
0
0
0
1.0×105
5.1×105
2.2×105
4.3×103
5.2×105
6.6×103
2.1×103
3.8×103
2.5×103
a The time when the blood samples were collected after i.p. injection, and 0 h means before injection.
b In these experiments, the same culture of B. fragilis was used for injection into two independent C 57/BL/6 J mice.
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if there was a sufficient number of cells in the sam-
ple. It was suggested that the PCR-dot blot hybridi-
zation assay using nanH was useful for the detec-
tion and quantification of B. fragilis present in clin-
ical specimens. Of course, NH1 can be applied for
the rapid identification of cultured B. fragilis, but
there are many cases in which the culture of blood
from a patient is negative even when septicemia is
suspected from clinical signs due to the adminis-
tration of antibiotics or, particularly in cases of an-
aerobic infection, due to storage of anaerobes un-
der inappropriate conditions. Furthermore, in al-
most all cases, clinical samples do not contain a
sufficient number of cells to enable detection using
direct hybridization assay. Therefore, an amplifica-
tion step is needed before performing the hybridi-
zation assay to obtain accurate results.
In the present study, we demonstrated the use-
fulness of PCR-dot blot hybridization based on the
neuraminidase-encoding gene for specific detec-
tion of B. fragilis cells using bateremia model mice.
It was suggested that a combination of the method
used in the present study with a traditional culture
method would be useful for a clinical survey of the
accurate incidence of B. fragilis infection and for
differential diagnosis in patients with fever of un-
known origin. However, it is necessary to deter-
mine whether this procedure is useful in the clin-
ical setting by performing tests using various clin-
ical samples such as pus, sputum and drainage flu-
id in a future study.
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